PlasmoClean joins university-based CAP-A study group

The collaboration advances research on Cold Atmospheric Plasma-Aerosol (CAP-A)

PlasmoClean ApS has joined a multidisciplinary, university-based study group evaluating the clinical use of Cold Atmospheric Plasma-Aerosol.

The group will conduct projects across veterinary and human medicine, including cell culture studies examining CAP-A–mediated inhibition of cancer cell growth.

The objective is to publish clinically relevant findings in peer-reviewed journals.

For inquiries please contact: info@plasmoClean.dk